Home/Filings/4/A/0001209191-13-041518
4/A//SEC Filing

MEI Pharma, Inc. 4/A

Accession 0001209191-13-041518

$LITSCIK 0001262104operating

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 3:13 PM ET

Size

6.4 KB

Accession

0001209191-13-041518

Insider Transaction Report

Form 4/AAmended
Period: 2012-12-21
Transactions
  • Purchase

    Common Stock, par value $0.00000002 per share

    2012-12-21$7.19/sh+1,800$12,9404,300 total
  • Purchase

    Common Stock, par value $0.00000002 per share

    2012-12-21$7.17/sh+1,700$12,1831,700 total(indirect: By Spouse)
Footnotes (1)
  • [F1]This amendment is being filed to correct the number of shares beneficially owned indirectly by the reporting person, which were originally reported on an aggregate basis with the shares held directly by the reporting person.

Issuer

MEI Pharma, Inc.

CIK 0001262104

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001262104

Filing Metadata

Form type
4/A
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 3:13 PM ET
Size
6.4 KB